メインコンテンツに移動

STP for OTC

Implementing straight-through processing for over-the-counter derivatives is no easy task. Kishore Kumar Ramakrishnan of JP Morgan outlines the challenges involved and makes recommendations for how to tackle them

Innovation appears to be the name of the game in over-the-counter (OTC) derivatives. Given the myriad new products in OTC derivatives markets, it has turned out to be a complex affair minimising the risk of trading and settling such instruments. This, coupled with increased usage of OTC derivatives products, seems to bring about constant shifts in the OTC trading and trade-processing landscape.

Not

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here